Latanoprost 50micrograms/ml eye drops
Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Patient Information leaflet
(PIL)
19-06-2018
Summary of Product characteristics
(SPC)
19-06-2018
Active ingredient:
Latanoprost
Available from:
Martindale Pharmaceuticals Ltd
ATC code:
S01EE01
INN (International Name):
Latanoprost
Dosage:
50microgram/1ml
Pharmaceutical form:
Eye drops
Administration route:
Ocular
Class:
No Controlled Drug Status
Prescription type:
Valid as a prescribable product
Product summary:
BNF: 11060000; GTIN: 5026468744503
Patient Information leaflet
1
PACKAGE LEAFLET: INFORMATION FOR THE USER
LATANOPROST 0.005% W/V EYE DROPS SOLUTION
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you or for your child only. Do
not pass it on to others. It
may harm them, even if their symptoms of illness are the same as
yours.
-
If you get any side effects, talk to your doctor
or the doctor treating your child
or pharmacist.
This includes any possible side effects not listed in this leaflet.
See section 4.
WHAT IS IN THIS LEAFLET:
1.
What Latanoprost eye drops is and what it is used for
2.
What you need to know before you use Latanoprost eye drops
3.
How to use Latanoprost eye drops
4.
Possible side effects
5.
How to store Latanoprost eye drops
6.
Contents of the pack and other information
1.
WHAT LATANOPROST EYE DROPS IS AND WHAT IT IS USED FOR
Latanoprost eye drops belongs to a group of medicines known as
prostaglandin analogues. It lowers
the pressure within your eye by increasing the natural flow of fluid
from inside the eye into the
blood stream.
Latanoprost eye drops is used to treat adults with open angle glaucoma
and ocular hypertension.
These conditions are linked with an increase in the pressure within
your eye. If they are not treated
they may affect your eyesight.
Latanoprost eye drops is also used to treat increased eye pressure and
glaucoma in all ages of
children and babies.
2.
WHAT YOU NEED TO KNOW BEFORE YOU USE LATANOPROST EYE DROPS
Latanoprost eye drops can be used in adults (including the elderly)
and in children from birth to 18
years of age. Latanoprost eye drops has not been investigated in
prematurely born infants (less than
36 weeks gestation).
DO NOT USE LATANOPROST EYE DROPS
- if you are
ALLERGIC
(hypersensitive) to latanoprost or any of the other ingredients of
Latanoprost
eye drops (listed in section 6)
- if you are
Read the complete document
Summary of Product characteristics
OBJECT 1
LATANOPROST 0.005% W/V EYE DROPS SOLUTION
Summary of Product Characteristics Updated 09-Dec-2016 | Martindale
Pharma
1. Name of the medicinal product
Latanoprost 0.005% w/v eye drops solution.
2. Qualitative and quantitative composition
Each millilitre (ml) of latanoprost eye drops solution contains 50 mcg
of latanoprost.
One drop contains approximately 1.5 micrograms latanoprost.
Excipient with known effect: Benzalkonium chloride 0.02% w/v as a
preservative.
For a full list of excipients, see section 6.1.
3. Pharmaceutical form
Eye drops, solution.
The solution is a clear colourless liquid.
4. Clinical particulars
4.1 Therapeutic indications
Reduction of elevated intraocular pressure in patients with open angle
glaucoma and ocular hypertension.
Reduction of elevated intraocular pressure in paediatric patients with
elevated intraocular pressure and
paediatric glaucoma.
4.2 Posology and method of administration
Posology
_Recommended dosage for adults (including the elderly):_
Recommended therapy is one eye drop in the affected eye(s) once daily.
Optimal effect is obtained if
Latanoprost eye drops is administered in the evening.
The dosage of Latanoprost eye drops should not exceed once daily since
it has been shown that more
frequent administration decreases the intraocular pressure lowering
effect.
If one dose is missed, treatment should continue with the next dose as
normal.
Method of administration
As with any eye drops, to reduce possible systemic absorption, it is
recommended that the lachrymal sac
be compressed at the medial canthus (punctal occlusion) for one
minute. This should be performed
immediately following the instillation of each drop.
Contact lenses should be removed before instillation of the eye drops
and may be reinserted after 15
minutes.
If more than one topical ophthalmic drug is being used, the drugs
should be administered at least five
minutes apart.
_Paediatric population_
Latanoprost eye drops may be used in paediatric patients at the same
posology as in adults. No data are
avail
Read the complete document
